HSBC Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $92.6M | Buy |
725,538
+87,009
| +14% | +$10.9M | 0.05% | 355 |
|
|
2025
Q4 | $78M | Buy |
638,529
+46,339
| +8% | +$5.31M | 0.04% | 388 |
|
|
2025
Q3 | $59M | Sell |
592,190
-118,565
| -17% | -$10.7M | 0.03% | 447 |
|
|
2025
Q2 | $58.9M | Sell |
710,755
-108,512
| -13% | -$8.66M | 0.04% | 439 |
|
|
2025
Q1 | $65.4M | Sell |
819,267
-272,796
| -25% | -$24.4M | 0.04% | 408 |
|
|
2024
Q4 | $98.3M | Buy |
1,092,063
+325,066
| +42% | +$31.5M | 0.06% | 303 |
|
|
2024
Q3 | $75.7M | Buy |
766,997
+703,026
| +1,099% | +$69.1M | 0.04% | 386 |
|
|
2024
Q2 | $5.91M | Sell |
63,971
-883,176
| -93% | -$79.2M | ﹤0.01% | 1009 |
|
|
2024
Q1 | $90M | Sell |
947,147
-201,136
| -18% | -$18.7M | 0.06% | 308 |
|
|
2023
Q4 | $103M | Buy |
1,148,283
+349,374
| +44% | +$25.9M | 0.09% | 222 |
|
|
2023
Q3 | $58.3M | Buy |
798,909
+317,632
| +66% | +$25.4M | 0.06% | 331 |
|
|
2023
Q2 | $40.3M | Sell |
481,277
-573,175
| -54% | -$47.9M | 0.04% | 437 |
|
|
2023
Q1 | $80.4M | Sell |
1,054,452
-20,515
| -2% | -$1.7M | 0.1% | 206 |
|
|
2022
Q4 | $87.4M | Buy |
1,074,967
+100,692
| +10% | +$8.15M | 0.1% | 205 |
|
|
2022
Q3 | $78.8M | Buy |
974,275
+234,186
| +32% | +$19.7M | 0.13% | 140 |
|
|
2022
Q2 | $55.4M | Buy |
740,089
+304,862
| +70% | +$22.9M | 0.08% | 244 |
|
|
2022
Q1 | $39.6M | Buy |
435,227
+284,576
| +189% | +$26.3M | 0.05% | 377 |
|
|
2021
Q4 | $17.2M | Buy |
150,651
+62,741
| +71% | +$7.57M | 0.02% | 726 |
|
|
2021
Q3 | $11.2M | Sell |
87,910
-24,065
| -21% | -$3.1M | 0.01% | 839 |
|
|
2021
Q2 | $15.3M | Sell |
111,975
-425
| -0.4% | -$55.9K | 0.02% | 720 |
|
|
2021
Q1 | $15.2M | Buy |
112,400
+69,195
| +160% | +$10.4M | 0.02% | 682 |
|
|
2020
Q4 | $6.09M | Buy |
43,205
+12,561
| +41% | +$1.61M | 0.01% | 947 |
|
|
2020
Q3 | $3.42M | Sell |
30,644
-12,602
| -29% | -$1.41M | 0.01% | 1095 |
|
|
2020
Q2 | $4.84M | Buy |
43,246
+18,242
| +73% | +$1.8M | 0.01% | 871 |
|
|
2020
Q1 | $1.94M | Buy |
25,004
+3,610
| +17% | +$320K | ﹤0.01% | 1197 |
|
|
2019
Q4 | $2.04M | Sell |
21,394
-93,953
| -81% | -$8.13M | ﹤0.01% | 1495 |
|
|
2019
Q3 | $8.79M | Buy |
115,347
+47,140
| +69% | +$3.92M | 0.02% | 912 |
|
|
2019
Q2 | $5.98M | Sell |
68,207
-56,039
| -45% | -$4.78M | 0.01% | 1067 |
|
|
2019
Q1 | $11.2M | Sell |
124,246
-235,144
| -65% | -$20M | 0.02% | 748 |
|
|
2018
Q4 | $25.8M | Buy |
359,390
+212,038
| +144% | +$17.1M | 0.05% | 407 |
|
|
2018
Q3 | $14.1M | Buy |
147,352
+124,673
| +550% | +$12.1M | 0.02% | 700 |
|
|
2018
Q2 | $2.16M | Sell |
22,679
-65,789
| -74% | -$6.05M | ﹤0.01% | 1469 |
|
|
2018
Q1 | $7.76M | Buy |
88,468
+7,364
| +9% | +$672K | 0.01% | 922 |
|
|
2017
Q4 | $6.88M | Buy |
81,104
+59,260
| +271% | +$4.96M | 0.01% | 775 |
|
|
2017
Q3 | $1.89M | Buy |
21,844
+290
| +1% | +$23.2K | ﹤0.01% | 1314 |
|
|
2017
Q2 | $1.66M | Buy |
21,554
+160
| +0.7% | +$11.3K | ﹤0.01% | 1324 |
|
|
2017
Q1 | $1.48M | Hold |
21,394
| – | – | ﹤0.01% | 1309 |
|
|
2016
Q4 | $1.27M | Hold |
21,394
| – | – | ﹤0.01% | 1337 |
|
|
2016
Q3 | $1.42M | Buy |
+21,394
| New | +$1.32M | ﹤0.01% | 1273 |
|
|
2016
Q2 | – | Sell |
-24,838
| Closed | -$1.28M | – | 2168 |
|
|
2016
Q1 | $1.28M | Buy |
24,838
+4,569
| +23% | +$237K | ﹤0.01% | 1256 |
|
|
2015
Q4 | $1.42M | Buy |
20,269
+908
| +5% | +$61.9K | ﹤0.01% | 1356 |
|
|
2015
Q3 | $1.21M | Sell |
19,361
-14,602
| -43% | -$1.15M | ﹤0.01% | 1181 |
|
|
2015
Q2 | $2.86M | Buy |
33,963
+11,979
| +54% | +$932K | 0.01% | 982 |
|
|
2015
Q1 | $1.65M | Buy |
21,984
+1,020
| +5% | +$71.3K | ﹤0.01% | 1220 |
|
|
2014
Q4 | $1.3M | Buy |
20,964
+273
| +1% | +$15.6K | ﹤0.01% | 1246 |
|
|
2014
Q3 | $1.08M | Buy |
20,691
+288
| +1% | +$14.7K | ﹤0.01% | 1311 |
|
|
2014
Q2 | $1.05M | Buy |
20,403
+219
| +1% | +$9.87K | ﹤0.01% | 1289 |
|
|
2014
Q1 | $959K | Buy |
20,184
+429
| +2% | +$22K | ﹤0.01% | 1244 |
|
|
2013
Q4 | $857K | Sell |
19,755
-8,100
| -29% | -$335K | ﹤0.01% | 1301 |
|
|
2013
Q3 | $1.2M | Buy |
27,855
+555
| +2% | +$22.5K | ﹤0.01% | 1200 |
|
|
2013
Q2 | $949K | Buy |
+27,300
| New | +$959K | ﹤0.01% | 1089 |
|
Other funds holding XBI
HSBC Holdings's XBI Position: Q1 2026 in Review
HSBC Holdings increased its State Street SPDR S&P Biotech ETF (XBI) stake by 14% in Q1 2026, buying an estimated $10.9M and bringing the position to 725,538 shares worth $92.6M. The position accounts for 0.05% of the portfolio, ranked #355.
HSBC Holdings first reported a position in XBI in Q2 2013 and has held it in 51 quarters since. The position peaked at $103M in Q4 2023. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- HSBC Holdings held 725,538 shares of State Street SPDR S&P Biotech ETF worth $92.6M as of Q1 2026.
- HSBC Holdings bought 87,009 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $10.9M.
- State Street SPDR S&P Biotech ETF made up 0.05% of HSBC Holdings's portfolio in Q1 2026, its #355 holding.
- HSBC Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 51 quarters since.
- HSBC Holdings's State Street SPDR S&P Biotech ETF position peaked at $103M in Q4 2023.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.